25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Natco Pharma Limited
Buy, Hold or Sell?

Let's analyze Natco Pharma Limited together

I guess you are interested in Natco Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Natco Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Natco Pharma Limited

I send you an email if I find something interesting about Natco Pharma Limited.

1. Quick Overview

1.1. Quick analysis of Natco Pharma Limited (30 sec.)










1.2. What can you expect buying and holding a share of Natco Pharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.45
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR326.79
Expected worth in 1 year
INR-368.20
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
INR-656.85
Return On Investment
-41.5%

For what price can you sell your share?

Current Price per Share
INR1,582.50
Expected price per share
INR1,307 - INR
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Natco Pharma Limited (5 min.)




Live pricePrice per Share (EOD)
INR1,582.50
Intrinsic Value Per Share
INR245.60 - INR921.00
Total Value Per Share
INR572.39 - INR1,247.78

2.2. Growth of Natco Pharma Limited (5 min.)




Is Natco Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$696.5m$1b-$390.8m-56.1%

How much money is Natco Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$165.2m$85.1m$80m48.5%
Net Profit Margin34.7%26.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Natco Pharma Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Natco Pharma Limited?

Welcome investor! Natco Pharma Limited's management wants to use your money to grow the business. In return you get a share of Natco Pharma Limited.

First you should know what it really means to hold a share of Natco Pharma Limited. And how you can make/lose money.

Speculation

The Price per Share of Natco Pharma Limited is INR1,583. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Natco Pharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Natco Pharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR326.79. Based on the TTM, the Book Value Change Per Share is INR-173.75 per quarter. Based on the YOY, the Book Value Change Per Share is INR266.80 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR9.54 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Natco Pharma Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.920.1%0.920.1%0.470.0%0.420.0%0.350.0%
Usd Book Value Change Per Share-2.07-0.1%-2.07-0.1%3.170.2%0.330.0%0.340.0%
Usd Dividend Per Share0.110.0%0.110.0%0.070.0%0.080.0%0.070.0%
Usd Total Gains Per Share-1.95-0.1%-1.95-0.1%3.240.2%0.410.0%0.410.0%
Usd Price Per Share11.33-11.33-6.70-8.57-9.88-
Price to Earnings Ratio12.28-12.28-14.38-32.40-55.68-
Price-to-Total Gains Ratio-5.80--5.80-2.07-21.98-46.27-
Price to Book Ratio2.91-2.91-1.13-2.67-8.00-
Price-to-Total Gains Ratio-5.80--5.80-2.07-21.98-46.27-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.83175
Number of shares53
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.110.08
Usd Book Value Change Per Share-2.070.33
Usd Total Gains Per Share-1.950.41
Gains per Quarter (53 shares)-103.5721.70
Gains per Year (53 shares)-414.2786.81
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
124-438-424177077
248-877-83835139164
372-1315-125252209251
496-1753-166669278338
5120-2192-208086348425
6144-2630-2494104417512
7168-3068-2908121487599
8192-3507-3322138556686
9217-3945-3736155626773
10241-4383-4150173696860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%20.00.00.0100.0%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%19.01.00.095.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%19.00.01.095.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%19.01.00.095.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Natco Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---173.748-173.7480%266.797-165%27.571-730%28.588-708%
Book Value Per Share--326.788326.7880%500.536-35%298.888+9%206.770+58%
Current Ratio--4.1364.1360%4.392-6%3.977+4%3.130+32%
Debt To Asset Ratio--0.1520.1520%-0.615+503%0.003+4277%0.134+14%
Debt To Equity Ratio--0.1800.1800%-0.714+497%0.008+2193%0.191-6%
Dividend Per Share--9.5369.5360%5.500+73%6.840+39%6.076+57%
Eps--77.51177.5110%39.183+98%35.086+121%29.259+165%
Free Cash Flow Per Share--49.89149.8910%35.250+42%16.005+212%9.258+439%
Free Cash Flow To Equity Per Share--37.11737.1170%15.365+142%5.070+632%6.835+443%
Gross Profit Margin--1.0001.0000%0.866+16%0.864+16%0.761+31%
Intrinsic Value_10Y_max--920.997--------
Intrinsic Value_10Y_min--245.598--------
Intrinsic Value_1Y_max--39.435--------
Intrinsic Value_1Y_min--13.263--------
Intrinsic Value_3Y_max--158.768--------
Intrinsic Value_3Y_min--49.914--------
Intrinsic Value_5Y_max--326.667--------
Intrinsic Value_5Y_min--97.315--------
Market Cap283441575000.000+40%170521675500.000170521675500.0000%102840874822.750+66%130838055286.130+30%149888958001.400+14%
Net Profit Margin--0.3470.3470%0.264+31%0.241+44%0.238+46%
Operating Margin--0.3910.3910%0.324+21%0.291+34%0.303+29%
Operating Ratio--0.6090.6090%0.715-15%0.738-18%0.720-15%
Pb Ratio4.843+40%2.9132.9130%1.125+159%2.673+9%8.004-64%
Pe Ratio20.416+40%12.28312.2830%14.377-15%32.397-62%55.676-78%
Price Per Share1582.500+40%952.050952.0500%563.350+69%720.530+32%830.060+15%
Price To Free Cash Flow Ratio31.719+40%19.08319.0830%15.981+19%92.552-79%-47.066+347%
Price To Total Gains Ratio-9.637-66%-5.798-5.7980%2.069-380%21.976-126%46.268-113%
Quick Ratio--3.1233.1230%4.478-30%3.597-13%2.854+9%
Return On Assets--0.2010.2010%0.126+59%0.111+82%0.128+57%
Return On Equity--0.2370.2370%0.147+62%0.131+82%0.164+45%
Total Gains Per Share---164.212-164.2120%272.297-160%34.412-577%34.664-574%
Usd Book Value--696518900.000696518900.0000%1087350600.000-36%646460360.000+8%446689374.048+56%
Usd Book Value Change Per Share---2.068-2.0680%3.175-165%0.328-730%0.340-708%
Usd Book Value Per Share--3.8893.8890%5.956-35%3.557+9%2.461+58%
Usd Dividend Per Share--0.1130.1130%0.065+73%0.081+39%0.072+57%
Usd Eps--0.9220.9220%0.466+98%0.418+121%0.348+165%
Usd Free Cash Flow--106338400.000106338400.0000%76576500.000+39%34362440.000+209%19932086.180+434%
Usd Free Cash Flow Per Share--0.5940.5940%0.419+42%0.190+212%0.110+439%
Usd Free Cash Flow To Equity Per Share--0.4420.4420%0.183+142%0.060+632%0.081+443%
Usd Market Cap3372954742.500+40%2029207938.4502029207938.4500%1223806410.391+66%1556972857.905+30%1783678600.217+14%
Usd Price Per Share18.832+40%11.32911.3290%6.704+69%8.574+32%9.878+15%
Usd Profit--165207700.000165207700.0000%85120700.000+94%75572140.000+119%62971125.207+162%
Usd Revenue--475857200.000475857200.0000%322144900.000+48%290095820.000+64%242650286.454+96%
Usd Total Gains Per Share---1.954-1.9540%3.240-160%0.410-577%0.412-574%
 EOD+3 -5MRQTTM+0 -0YOY+21 -155Y+26 -1010Y+28 -8

3.3 Fundamental Score

Let's check the fundamental score of Natco Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1520.416
Price to Book Ratio (EOD)Between0-14.843
Net Profit Margin (MRQ)Greater than00.347
Operating Margin (MRQ)Greater than00.391
Quick Ratio (MRQ)Greater than13.123
Current Ratio (MRQ)Greater than14.136
Debt to Asset Ratio (MRQ)Less than10.152
Debt to Equity Ratio (MRQ)Less than10.180
Return on Equity (MRQ)Greater than0.150.237
Return on Assets (MRQ)Greater than0.050.201
Total8/10 (80.0%)

3.4 Technical Score

Let's check the technical score of Natco Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.035
Ma 20Greater thanMa 501,539.203
Ma 50Greater thanMa 1001,405.030
Ma 100Greater thanMa 2001,236.167
OpenGreater thanClose1,604.400
Total5/5 (100.0%)

4. In-depth Analysis

4.1 About Natco Pharma Limited

NATCO Pharma Limited, a pharmaceutical company, engages in the developing, manufacturing, and marketing of finished dosage formulations, active pharmaceutical ingredients (APIs), and intermediates in India, the United States, and internationally. It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, and ovary; and APIs in various categories, such as oncology, central nervous system, pain management, and cardiovascular care. The company offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina, and CHF. Further, the company offers agro chemicals and biological pest management solutions for management of insects, diseases, and weeds across a range of crops. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

Fundamental data was last updated by Penke on 2024-09-14 18:37:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is underpriced.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Natco Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 34.7% means that ₹0.35 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Natco Pharma Limited:

  • The MRQ is 34.7%. The company is making a huge profit. +2
  • The TTM is 34.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ34.7%TTM34.7%0.0%
TTM34.7%YOY26.4%+8.3%
TTM34.7%5Y24.1%+10.6%
5Y24.1%10Y23.8%+0.3%
4.3.1.2. Return on Assets

Shows how efficient Natco Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 20.1% Return on Assets means that Natco Pharma Limited generated ₹0.20 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Natco Pharma Limited:

  • The MRQ is 20.1%. Using its assets, the company is very efficient in making profit. +2
  • The TTM is 20.1%. Using its assets, the company is very efficient in making profit. +2
Trends
Current periodCompared to+/- 
MRQ20.1%TTM20.1%0.0%
TTM20.1%YOY12.6%+7.5%
TTM20.1%5Y11.1%+9.0%
5Y11.1%10Y12.8%-1.8%
4.3.1.3. Return on Equity

Shows how efficient Natco Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 23.7% Return on Equity means Natco Pharma Limited generated ₹0.24 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Natco Pharma Limited:

  • The MRQ is 23.7%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.7%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.7%TTM23.7%0.0%
TTM23.7%YOY14.7%+9.0%
TTM23.7%5Y13.1%+10.7%
5Y13.1%10Y16.4%-3.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Natco Pharma Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Natco Pharma Limited is operating .

  • Measures how much profit Natco Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 39.1% means the company generated ₹0.39  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Natco Pharma Limited:

  • The MRQ is 39.1%. The company is operating very efficient. +2
  • The TTM is 39.1%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ39.1%TTM39.1%0.0%
TTM39.1%YOY32.4%+6.8%
TTM39.1%5Y29.1%+10.0%
5Y29.1%10Y30.3%-1.2%
4.3.2.2. Operating Ratio

Measures how efficient Natco Pharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.61 means that the operating costs are ₹0.61 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Natco Pharma Limited:

  • The MRQ is 0.609. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.609. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.609TTM0.6090.000
TTM0.609YOY0.715-0.106
TTM0.6095Y0.738-0.130
5Y0.73810Y0.720+0.019
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Natco Pharma Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Natco Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 4.14 means the company has ₹4.14 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Natco Pharma Limited:

  • The MRQ is 4.136. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.136. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.136TTM4.1360.000
TTM4.136YOY4.392-0.256
TTM4.1365Y3.977+0.159
5Y3.97710Y3.130+0.847
4.4.3.2. Quick Ratio

Measures if Natco Pharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.12 means the company can pay off ₹3.12 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Natco Pharma Limited:

  • The MRQ is 3.123. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 3.123. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.123TTM3.1230.000
TTM3.123YOY4.478-1.355
TTM3.1235Y3.597-0.474
5Y3.59710Y2.854+0.743
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Natco Pharma Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Natco Pharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Natco Pharma Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.15 means that Natco Pharma Limited assets are financed with 15.2% credit (debt) and the remaining percentage (100% - 15.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Natco Pharma Limited:

  • The MRQ is 0.152. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.152. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.152TTM0.1520.000
TTM0.152YOY-0.615+0.768
TTM0.1525Y0.003+0.149
5Y0.00310Y0.134-0.130
4.5.4.2. Debt to Equity Ratio

Measures if Natco Pharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 18.0% means that company has ₹0.18 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Natco Pharma Limited:

  • The MRQ is 0.180. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.180. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.180TTM0.1800.000
TTM0.180YOY-0.714+0.894
TTM0.1805Y0.008+0.172
5Y0.00810Y0.191-0.184
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Natco Pharma Limited generates.

  • Above 15 is considered overpriced but always compare Natco Pharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.28 means the investor is paying ₹12.28 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Natco Pharma Limited:

  • The EOD is 20.416. Based on the earnings, the company is fair priced.
  • The MRQ is 12.283. Based on the earnings, the company is underpriced. +1
  • The TTM is 12.283. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD20.416MRQ12.283+8.134
MRQ12.283TTM12.2830.000
TTM12.283YOY14.377-2.095
TTM12.2835Y32.397-20.114
5Y32.39710Y55.676-23.280
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Natco Pharma Limited:

  • The EOD is 31.719. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 19.083. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.083. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD31.719MRQ19.083+12.637
MRQ19.083TTM19.0830.000
TTM19.083YOY15.981+3.101
TTM19.0835Y92.552-73.469
5Y92.55210Y-47.066+139.618
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Natco Pharma Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 2.91 means the investor is paying ₹2.91 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Natco Pharma Limited:

  • The EOD is 4.843. Based on the equity, the company is fair priced.
  • The MRQ is 2.913. Based on the equity, the company is underpriced. +1
  • The TTM is 2.913. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD4.843MRQ2.913+1.929
MRQ2.913TTM2.9130.000
TTM2.913YOY1.125+1.788
TTM2.9135Y2.673+0.240
5Y2.67310Y8.004-5.331
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Net Debt  3,096,000-515,0002,581,000628,0003,209,000-2,861,000348,000-6,165,000-5,817,000
Other Stockholders Equity  20,484,000-6,569,00013,915,000163,00014,078,000-13,00014,065,000-58,722,000-44,657,000



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets69,063,000
Total Liabilities10,532,000
Total Stockholder Equity58,531,000
 As reported
Total Liabilities 10,532,000
Total Stockholder Equity+ 58,531,000
Total Assets = 69,063,000

Assets

Total Assets69,063,000
Total Current Assets40,235,000
Long-term Assets28,828,000
Total Current Assets
Cash And Cash Equivalents 9,529,000
Short-term Investments 4,435,000
Net Receivables 11,979,000
Inventory 7,005,000
Other Current Assets 7,287,000
Total Current Assets  (as reported)40,235,000
Total Current Assets  (calculated)40,235,000
+/-0
Long-term Assets
Property Plant Equipment 24,350,000
Goodwill 560,000
Intangible Assets 1,371,000
Long-term Assets Other 955,000
Long-term Assets  (as reported)28,828,000
Long-term Assets  (calculated)27,236,000
+/- 1,592,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,728,000
Long-term Liabilities804,000
Total Stockholder Equity58,531,000
Total Current Liabilities
Short-term Debt 3,659,000
Short Long Term Debt 3,632,000
Accounts payable 2,355,000
Other Current Liabilities 3,391,000
Total Current Liabilities  (as reported)9,728,000
Total Current Liabilities  (calculated)13,037,000
+/- 3,309,000
Long-term Liabilities
Capital Lease Obligations 80,000
Long-term Liabilities  (as reported)804,000
Long-term Liabilities  (calculated)80,000
+/- 724,000
Total Stockholder Equity
Common Stock358,000
Retained Earnings 44,657,000
Accumulated Other Comprehensive Income 58,173,000
Other Stockholders Equity -44,657,000
Total Stockholder Equity (as reported)58,531,000
Total Stockholder Equity (calculated)58,531,000
+/-0
Other
Capital Stock358,000
Cash and Short Term Investments 13,964,000
Common Stock Shares Outstanding 179,110
Current Deferred Revenue323,000
Liabilities and Stockholders Equity 69,063,000
Net Debt -5,817,000
Net Invested Capital 62,163,000
Net Working Capital 30,507,000
Property Plant and Equipment Gross 24,350,000
Short Long Term Debt Total 3,712,000



6.3. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-31
> Total Assets 
2,874,026
3,079,444
3,498,013
4,193,920
5,165,340
5,509,125
7,073,189
9,027,765
10,804,124
11,957,094
13,840,450
18,238,043
23,176,000
37,151,000
43,031,000
45,878,000
47,919,000
51,091,000
56,574,000
69,063,000
69,063,00056,574,00051,091,00047,919,00045,878,00043,031,00037,151,00023,176,00018,238,04313,840,45011,957,09410,804,1249,027,7657,073,1895,509,1255,165,3404,193,9203,498,0133,079,4442,874,026
   > Total Current Assets 
1,614,741
1,575,322
1,724,161
1,904,880
2,476,736
1,889,127
2,758,432
3,136,615
3,329,577
3,681,364
4,829,663
8,323,038
10,873,000
21,307,000
23,472,000
23,256,000
23,373,000
24,972,000
30,003,000
40,235,000
40,235,00030,003,00024,972,00023,373,00023,256,00023,472,00021,307,00010,873,0008,323,0384,829,6633,681,3643,329,5773,136,6152,758,4321,889,1272,476,7361,904,8801,724,1611,575,3221,614,741
       Cash And Cash Equivalents 
463,270
306,376
286,771
259,668
290,923
81,182
333,283
366,312
118,204
102,155
124,416
440,658
235,000
217,000
283,000
198,000
258,000
1,111,000
1,319,000
9,529,000
9,529,0001,319,0001,111,000258,000198,000283,000217,000235,000440,658124,416102,155118,204366,312333,28381,182290,923259,668286,771306,376463,270
       Short-term Investments 
439,989
429,695
583,870
581,934
859,935
460,415
691,960
7,375
8,122
3,180
1,183
209,642
1,137,000
8,246,000
10,293,000
8,827,000
7,844,000
6,488,000
10,302,000
4,435,000
4,435,00010,302,0006,488,0007,844,0008,827,00010,293,0008,246,0001,137,000209,6421,1833,1808,1227,375691,960460,415859,935581,934583,870429,695439,989
       Net Receivables 
0
0
0
0
0
572,364
709,790
946,902
1,449,414
1,460,970
2,150,714
3,698,695
5,273,000
7,166,000
6,856,000
6,333,000
4,706,000
6,710,000
8,663,000
11,979,000
11,979,0008,663,0006,710,0004,706,0006,333,0006,856,0007,166,0005,273,0003,698,6952,150,7141,460,9701,449,414946,902709,790572,36400000
       Inventory 
380,010
457,519
516,882
683,490
802,943
774,356
1,022,324
1,103,893
1,460,240
1,811,247
2,199,997
3,572,832
3,489,000
4,384,000
5,290,000
5,580,000
7,982,000
7,620,000
7,429,000
7,005,000
7,005,0007,429,0007,620,0007,982,0005,580,0005,290,0004,384,0003,489,0003,572,8322,199,9971,811,2471,460,2401,103,8931,022,324774,356802,943683,490516,882457,519380,010
       Other Current Assets 
331,471
381,732
336,638
379,787
522,936
809
1,075
712,132
293,598
303,813
353,352
401,210
739,000
1,294,000
750,000
8,651,000
2,583,000
3,043,000
2,290,000
7,287,000
7,287,0002,290,0003,043,0002,583,0008,651,000750,0001,294,000739,000401,210353,352303,813293,598712,1321,075809522,936379,787336,638381,732331,471
   > Long-term Assets 
1,259,285
1,504,122
1,773,852
2,289,041
2,688,603
3,619,998
4,314,757
5,891,151
7,474,547
8,275,730
9,010,787
9,915,005
12,303,000
15,844,000
19,559,000
22,622,000
24,546,000
26,119,000
26,571,000
28,828,000
28,828,00026,571,00026,119,00024,546,00022,622,00019,559,00015,844,00012,303,0009,915,0059,010,7878,275,7307,474,5475,891,1514,314,7573,619,9982,688,6032,289,0411,773,8521,504,1221,259,285
       Property Plant Equipment 
1,050,760
1,304,627
1,584,109
1,942,975
2,372,722
2,729,498
3,519,954
4,653,350
6,597,477
7,365,143
7,929,887
9,164,028
11,635,000
14,927,000
18,561,000
20,937,000
22,372,000
23,084,000
23,034,000
24,350,000
24,350,00023,034,00023,084,00022,372,00020,937,00018,561,00014,927,00011,635,0009,164,0287,929,8877,365,1436,597,4774,653,3503,519,9542,729,4982,372,7221,942,9751,584,1091,304,6271,050,760
       Goodwill 
0
0
164,608
338,563
309,253
274,383
151,768
0
238,729
255,995
410,263
36,939
0
0
0
0
0
507,000
552,000
560,000
560,000552,000507,0000000036,939410,263255,995238,7290151,768274,383309,253338,563164,60800
       Long Term Investments 
0
0
0
0
0
0
0
0
0
15,678
15,678
1,000
1,000
81,000
199,000
0
0
0
0
0
00000199,00081,0001,0001,00015,67815,678000000000
       Intangible Assets 
0
0
0
4,092
5,342
10,163
16,996
162,183
49,687
64,058
49,198
52,252
58,000
118,000
87,000
88,000
94,000
822,000
1,326,000
1,371,000
1,371,0001,326,000822,00094,00088,00087,000118,00058,00052,25249,19864,05849,687162,18316,99610,1635,3424,092000
       Other Assets 
0
0
0
0
0
0
0
0
0
574,856
605,760
185,000
609,000
777,000
712,000
762,000
486,000
662,000
271,000
0
0271,000662,000486,000762,000712,000777,000609,000185,000605,760574,856000000000
> Total Liabilities 
1,737,567
1,541,084
1,637,723
1,943,090
2,504,631
2,402,346
3,538,268
4,306,928
5,363,328
4,629,538
5,329,689
5,205,582
6,642,000
6,391,000
8,121,000
8,031,000
6,685,000
8,455,000
-34,800,000
10,532,000
10,532,000-34,800,0008,455,0006,685,0008,031,0008,121,0006,391,0006,642,0005,205,5825,329,6894,629,5385,363,3284,306,9283,538,2682,402,3462,504,6311,943,0901,637,7231,541,0841,737,567
   > Total Current Liabilities 
467,560
590,599
693,108
797,864
1,000,349
938,971
1,087,674
2,565,684
3,448,701
3,122,821
4,137,403
4,929,008
6,265,000
5,920,000
7,287,000
6,853,000
5,256,000
7,104,000
6,831,000
9,728,000
9,728,0006,831,0007,104,0005,256,0006,853,0007,287,0005,920,0006,265,0004,929,0084,137,4033,122,8213,448,7012,565,6841,087,674938,9711,000,349797,864693,108590,599467,560
       Short-term Debt 
0
0
0
0
0
0
0
816,422
1,477,435
1,459,577
2,161,995
1,125,160
2,216,000
1,732,000
3,863,000
3,285,000
2,830,000
4,240,000
1,656,000
3,659,000
3,659,0001,656,0004,240,0002,830,0003,285,0003,863,0001,732,0002,216,0001,125,1602,161,9951,459,5771,477,435816,4220000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
2,440,921
462,801
142,000
2,216,000
1,732,000
3,863,000
3,277,000
2,821,000
4,040,000
1,650,000
3,632,000
3,632,0001,650,0004,040,0002,821,0003,277,0003,863,0001,732,0002,216,000142,000462,8012,440,921000000000
       Accounts payable 
0
0
599,576
722,274
953,584
793,277
920,292
923,564
1,022,571
1,097,863
1,253,014
25,554
20,000
48,000
2,170,000
2,554,000
1,462,000
1,618,000
2,638,000
2,355,000
2,355,0002,638,0001,618,0001,462,0002,554,0002,170,00048,00020,00025,5541,253,0141,097,8631,022,571923,564920,292793,277953,584722,274599,57600
       Other Current Liabilities 
467,560
590,599
93,532
75,590
46,765
145,695
167,382
819,093
817,688
289,433
390,220
575,809
113,000
4,114,000
1,188,000
929,000
951,000
369,000
1,408,000
3,391,000
3,391,0001,408,000369,000951,000929,0001,188,0004,114,000113,000575,809390,220289,433817,688819,093167,382145,69546,76575,59093,532590,599467,560
   > Long-term Liabilities 
1,270,007
950,485
944,616
1,145,226
1,504,282
1,463,375
2,450,594
1,741,243
1,914,627
1,506,717
1,192,285
276,574
377,000
471,000
834,000
1,178,000
1,429,000
1,351,000
-41,631,000
804,000
804,000-41,631,0001,351,0001,429,0001,178,000834,000471,000377,000276,5741,192,2851,506,7171,914,6271,741,2432,450,5941,463,3751,504,2821,145,226944,616950,4851,270,007
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,000
9,000
80,000
11,000
0
011,00080,0009,0009,000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
551,854
222,128
280,000
377,000
471,000
834,000
1,169,000
1,420,000
1,271,000
994,000
0
0994,0001,271,0001,420,0001,169,000834,000471,000377,000280,000222,128551,854000000000
> Total Stockholder Equity
1,136,460
1,478,488
1,803,033
2,182,822
2,591,198
3,057,377
3,524,331
4,711,998
5,335,429
7,258,760
8,460,511
12,983,338
16,493,000
30,722,000
34,890,000
37,735,000
41,216,000
42,636,000
48,738,000
58,531,000
58,531,00048,738,00042,636,00041,216,00037,735,00034,890,00030,722,00016,493,00012,983,3388,460,5117,258,7605,335,4294,711,9983,524,3313,057,3772,591,1982,182,8221,803,0331,478,4881,136,460
   Common Stock
261,614
271,744
276,448
280,408
280,408
281,480
281,480
311,480
313,731
330,731
332,348
348,348
349,000
369,000
365,000
364,000
365,000
365,000
365,000
358,000
358,000365,000365,000365,000364,000365,000369,000349,000348,348332,348330,731313,731311,480281,480281,480280,408280,408276,448271,744261,614
   Retained Earnings 
64,928
258,421
494,310
824,346
1,193,057
1,574,375
2,003,840
2,421,321
2,914,161
3,638,035
4,673,995
5,663,752
9,094,000
14,239,000
19,575,000
22,391,000
25,682,000
26,666,000
32,923,000
44,657,000
44,657,00032,923,00026,666,00025,682,00022,391,00019,575,00014,239,0009,094,0005,663,7524,673,9953,638,0352,914,1612,421,3212,003,8401,574,3751,193,057824,346494,310258,42164,928
   Accumulated Other Comprehensive Income 
-390,079
-456,061
-532,678
-621,731
-731,952
-872,257
-1,006,783
-1,163,809
-1,389,199
-1,682,880
-2,216,337
-2,677,884
-3,184,000
-3,800,000
-4,576,000
-5,504,000
1,254,000
1,527,000
1,385,000
58,173,000
58,173,0001,385,0001,527,0001,254,000-5,504,000-4,576,000-3,800,000-3,184,000-2,677,884-2,216,337-1,682,880-1,389,199-1,163,809-1,006,783-872,257-731,952-621,731-532,678-456,061-390,079
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
6,112,000
6,178,000
15,206,000
14,048,000
13,729,000
13,915,000
14,078,000
14,065,000
0
014,065,00014,078,00013,915,00013,729,00014,048,00015,206,0006,178,0006,112,00000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
1,199,997
1,404,384
1,564,953
1,699,798
1,849,684
2,073,779
2,245,793
3,143,007
3,496,736
4,972,875
5,670,505
9,649,121
10,234,000
19,914,000
19,526,000
20,484,000
13,915,000
14,078,000
14,065,000
-44,657,000
-44,657,00014,065,00014,078,00013,915,00020,484,00019,526,00019,914,00010,234,0009,649,1215,670,5054,972,8753,496,7363,143,0072,245,7932,073,7791,849,6841,699,7981,564,9531,404,3841,199,997



6.4. Balance Sheets

Currency in INR. All numbers in thousands.




6.5. Cash Flows

Currency in INR. All numbers in thousands.




6.6. Income Statements

Currency in INR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue39,988,000
Cost of Revenue-14,284,000
Gross Profit25,704,00025,704,000
 
Operating Income (+$)
Gross Profit25,704,000
Operating Expense-10,058,000
Operating Income15,646,00015,646,000
 
Operating Expense (+$)
Research Development1,211,000
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense10,058,0001,211,000
 
Net Interest Income (+$)
Interest Income0
Interest Expense-192,000
Other Finance Cost-0
Net Interest Income-192,000
 
Pretax Income (+$)
Operating Income15,646,000
Net Interest Income-192,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)16,735,00014,557,000
EBIT - interestExpense = 15,454,000
16,735,000
14,075,000
Interest Expense192,000
Earnings Before Interest and Taxes (EBIT)15,646,00016,927,000
Earnings Before Interest and Taxes (EBITDA)17,514,000
 
After tax Income (+$)
Income Before Tax16,735,000
Tax Provision-2,852,000
Net Income From Continuing Ops13,883,00013,883,000
Net Income13,883,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses24,342,000
Total Other Income/Expenses Net1,089,000192,000
 

Technical Analysis of Natco Pharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Natco Pharma Limited. The general trend of Natco Pharma Limited is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Natco Pharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Natco Pharma Limited.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: .

The bearish price targets are: 1,585 > 1,344 > 1,307.

Tweet this
Natco Pharma Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Natco Pharma Limited. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Natco Pharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Natco Pharma Limited. The current macd is 48.49.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Natco Pharma Limited price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Natco Pharma Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Natco Pharma Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Natco Pharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartNatco Pharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Natco Pharma Limited. The current adx is 27.65.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Natco Pharma Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Natco Pharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Natco Pharma Limited. The current sar is 1,546.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Natco Pharma Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Natco Pharma Limited. The current rsi is 67.04. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Natco Pharma Limited Daily Relative Strength Index (RSI) ChartNatco Pharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Natco Pharma Limited. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Natco Pharma Limited price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Natco Pharma Limited Daily Stochastic Oscillator ChartNatco Pharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Natco Pharma Limited. The current cci is 113.65.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Natco Pharma Limited Daily Commodity Channel Index (CCI) ChartNatco Pharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Natco Pharma Limited. The current cmo is 32.78.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Natco Pharma Limited Daily Chande Momentum Oscillator (CMO) ChartNatco Pharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Natco Pharma Limited. The current willr is -37.95767551.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Natco Pharma Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Natco Pharma Limited Daily Williams %R ChartNatco Pharma Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Natco Pharma Limited.

Natco Pharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Natco Pharma Limited. The current atr is 52.75.

Natco Pharma Limited Daily Average True Range (ATR) ChartNatco Pharma Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Natco Pharma Limited. The current obv is 103,418,692.

Natco Pharma Limited Daily On-Balance Volume (OBV) ChartNatco Pharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Natco Pharma Limited. The current mfi is 72.64.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Natco Pharma Limited Daily Money Flow Index (MFI) ChartNatco Pharma Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Natco Pharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-05-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-05-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-05-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-05-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-05-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-05-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-30MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-31SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-06-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-10MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-06-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-06-25RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-07-22MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-23SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-08-14RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-08-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-13STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Natco Pharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Natco Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.035
Ma 20Greater thanMa 501,539.203
Ma 50Greater thanMa 1001,405.030
Ma 100Greater thanMa 2001,236.167
OpenGreater thanClose1,604.400
Total5/5 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Natco Pharma Limited with someone you think should read this too:
  • Are you bullish or bearish on Natco Pharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Natco Pharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Natco Pharma Limited

I send you an email if I find something interesting about Natco Pharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Natco Pharma Limited.

Receive notifications about Natco Pharma Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.